Science In The Courts

Your opinion page features headlined "Disorder In The Court When Science Takes The Witness Stand" [The Scientist, Oct. 29, 1990, page 15] were timely and to the point. The writer, Edward J. Imwinkelried, argues persuasively [ in "Court Rules Work To Exclude Valid Scientific Testimony"] for allowing scientists to help set procedural ground rules for admissibility of scientific evidence rather than waiting for such science to pass the popularity poll implied in the so-called Frye, or general acce

Written byJon Zonderman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your opinion page features headlined "Disorder In The Court When Science Takes The Witness Stand" [The Scientist, Oct. 29, 1990, page 15] were timely and to the point. The writer, Edward J. Imwinkelried, argues persuasively [ in "Court Rules Work To Exclude Valid Scientific Testimony"] for allowing scientists to help set procedural ground rules for admissibility of scientific evidence rather than waiting for such science to pass the popularity poll implied in the so-called Frye, or general acceptance, test.

I'd like to focus on his discussion of research into how juries accept and synthesize scientific evidence. His main citation for stating that jurors are inquisitive and look on scientific evidence critically--rather than being under the "spell" of scientific expertise, as California's Supreme Court once cautioned--is a 25-year-old study by the Chicago Jury Project.

But times have changed, and I believe juries today--indeed, our country's citizens--are beset by far more complex ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies